Fundraising Fox
Steve Curtis
InvestorManaging Director at BrightEdge
Find your path to Steve
20 people in our graph can introduce you to Steve.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Caitlin Tolman to introduce you to Steve
You →Caitlin · together at BrightEdge →Steve
Ask Jamie Chen to introduce you to Steve
You →Jamie · 11 people · together at BrightEdge →Steve
Sign up to find every way you can get introduced to Steve
- Your email: the people you already email who know Steve
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Steve
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Steve Curtis is Director of New Ventures at BrightEdge, the impact venture capital arm of the ACS. He previously managed MPM Capital's Oncology Innovations Fund, a venture/philanthropy collaboration with Dana-Farber Cancer Institute, where he invested in seed and Series A biotech companies. Earlier roles include Senior Director of Business Development at Eli Lilly, co-leading the Bioscience Ventures group at 2M Companies, and running technology in-licensing at Reata Pharmaceuticals.
Invests in
BiotechImpact & Social Good
Colleagues at BrightEdge
Frequently asked questions
- Who is Steve Curtis?
- Steve Curtis is Director of New Ventures at BrightEdge, the impact venture capital arm of the ACS. He previously managed MPM Capital's Oncology Innovations Fund, a venture/philanthropy collaboration with Dana-Farber Cancer Institute, where he invested in seed and Series A biotech companies. Earlier roles include Senior Director of Business Development at Eli Lilly, co-leading the Bioscience Ventures group at 2M Companies, and running technology in-licensing at Reata Pharmaceuticals.
- Where does Steve Curtis work?
- Steve Curtis is Managing Director at BrightEdge.
- What does Steve Curtis invest in?
- Steve Curtis invests in Biotech, Impact & Social Good.